Literature DB >> 21233136

Utilization of legal and financial services of partners in dementia care study.

Srijana Shrestha1, Katherine S Judge, Nancy L Wilson, Jennifer A Moye, A Lynn Snow, Mark E Kunik.   

Abstract

Financial and legal services are unique needs of persons with dementia and their caregivers. This study examines their need for legal and financial assistance and the kinds of legal and financial services provided within Partners in Dementia Care, a telephone-based, care coordination and support service intervention delivered through a partnership between Veterans Affairs (VA) medical centers and local Alzheimer's Association chapters. Based on comprehensive assessment, and needs prioritization, care coordinators collaboratively planned action steps (specific behavioral tasks) with each caregiver/person with dementia to address the dyad's identified unmet needs. Results show that 51 (54.8%) of 93 dyads reported a need for legal and financial services. Action steps related to legal and financial need included education or assistance with legal services (27.27%), nonhealth-related financial benefits (32.32%), health-related financial benefits (21.21%), financial management/planning (9.09%), and financial support (10.1%). Comparable numbers of action steps were directed to VA (41.4%) and non-VA (58.6%) services.

Entities:  

Mesh:

Year:  2011        PMID: 21233136     DOI: 10.1177/1533317510394156

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  2 in total

1.  A comparison of negative financial events experienced by carers and non-carers following onset of the Great Recession.

Authors:  Kylie Meyer; Zachary Gassoumis; Kathleen Wilber
Journal:  Int J Care Caring       Date:  2021-06-21

2.  Increased healthcare service utilizations for patients with dementia: a population-based study.

Authors:  Shiu-Dong Chung; Shih-Ping Liu; Jau-Jiuan Sheu; Ching-Chun Lin; Herng-Ching Lin; Chao-Hung Chen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.